Aarey Drugs & Pharmaceuticals Ltd.

View in App
46.90 -0.23 ▼-0.5%

04 October 2023, 04:01:00 PM
Volume: 3,681

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aareydrugs.com
Market Cap 119.05 Cr.
Enterprise Value(EV) 156.07 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 1.46 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 32.17 Trailing Twelve Months Ending 2023-06
Industry PE 37.76 Trailing Twelve Months Ending 2023-06
Book Value / Share 45.63 Trailing Twelve Months Ending 2023-06
Price to Book Value 1.03 Calculated using Price: 46.90
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.54 Cr. 25,384,684 Shares
FaceValue 10
About Aarey Drugs & Pharmaceuticals Ltd.
Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

Aarey Drugs & Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Aarey Drugs & Pharmaceuticals Ltd. Performance

View details >>
1 Day
-0.49%
1 Week
-3.32%
1 Month
-1.90%
3 Month
+37.86%
6 Month
+87.15%
1 Year
+21.98%
2 Year
+28.67%
5 Year
+41.69%
10 Year
+394.20%

Aarey Drugs & Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3.12 3.58 12.90 9.80 8.07 6.65 6.98 6.31 3.33
Return on Capital Employed (%) 6.69 7.23 22.21 14.14 12.05 8.48 9.46 9.87 6.27
Return on Assets (%) 0.98 1.07 4.09 3.96 4.15 3.41 3.05 2.74 1.41

Aarey Drugs & Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 35 35 37 49 80 87 92 99 114 117
Non Curr. Liab. 0 0 2 1 2 1 3 5 6
Curr. Liab. 72 80 88 92 88 58 100 131 127 168
Minority Int.
Equity & Liab. 107 115 125 143 170 146 194 233 245 291
Non Curr. Assets 5 6 8 13 13 13 13 15 26 21
Curr. Assets 102 109 117 130 157 133 181 218 219 271
Misc. Exp. not W/O 0 0
Total Assets 107 115 125 143 170 146 194 233 245 291

Aarey Drugs & Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 213 246 396 349 355 300 348 493 419 348
Other Income 3 3 3 3 4 7 7 3 3 6
Total Income 216 249 399 352 359 307 355 495 422 354
Total Expenditure -212 -245 -386 -341 -347 -297 -344 -481 -411 -343
PBIDT 4 4 13 11 12 10 12 14 10 11
Interest -1 -2 -4 -2 -2 -2 -2 -2 -3 -3
Depreciation -1 -1 -1 -1 -1 -1 -1 -2 -2 -2
Taxation 0 -1 -3 -2 -2 -1 -2 -3 -2 -2
Exceptional Items
PAT 1 1 5 6 7 6 7 7 4 4
Adjusted EPS 1 1 3 3 3 2 3 3 1 1

Aarey Drugs & Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 3 6 1 -20 1 3 5 1 -1
Cash Fr. Inv. 2 -2 -3 -5 -1 -1 -1 -3 -3 0
Cash Fr. Finan. -1 -2 -2 4 23 -2 -2 -2 2 1
Net Change 0 -1 1 -1 2 -3 0 0 0 1
Cash & Cash Eqvt 1 0 2 1 3 0 1 1 0 1

Aarey Drugs & Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 49.38 49.38 48.05 48.06 50.03 50.03 50.03 50.04 50.04
Public 50.62 50.62 51.95 51.94 49.97 49.97 49.97 49.96 49.96
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Aarey Drugs & Pharmaceuticals Ltd. Announcements

View details >>
Sat, 30 Sep 2023
Closure of Trading Window
Closure of trading window
Wed, 06 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Shareholder Meeting - Scrutinizers Report
Wed, 06 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Shareholders meeting proceedings

Aarey Drugs & Pharmaceuticals Ltd. Technical Scans

View details >>
Wed, 04 Oct 2023
Opening at High Opening at High
Opening at High for 2 Days Opening at High for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Aarey Drugs & Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,145.40 1,121.75 -1.8%
Divi's Laboratories Ltd. 98,393.27 3,702.05 -0.5%
Cipla Ltd. 94,222.95 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. 90,284.76 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. 72,588.97 5,048.70 -1.4%
Mankind Pharma Ltd. 72,396.35 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. 63,113.31 1,865.70 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.91 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 66.52 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 30.29 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.12 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.58 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.53 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.11 1,865.70 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.64 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 7.49 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 3.87 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.68 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.57 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.92 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.60 1,865.70 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,865.70 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,865.70 -0.8%

Aarey Drugs & Pharmaceuticals Ltd. FAQ's

What is Aarey Drugs & Pharma share price?
Can I buy Aarey Drugs & Pharma shares now?
What is the Market Cap of Aarey Drugs & Pharma?
What are the key metrics to analyse Aarey Drugs & Pharma?
What is the 52 Week High and Low of Aarey Drugs & Pharma?
What is the trend of Aarey Drugs & Pharma share price?